2025 annual financial data
Janux Therapeutics 2025 Operating margin
Janux Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -1,576.67%.
Operating income was -157,667,000 USD and net income was -113,625,000 USD.
Operating cash flow was Not available.
Get free Janux Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000,000 USD
- Operating income
- -157,667,000 USD
- Net income
- -113,625,000 USD
- Operating cash flow
- Not available